Skip to main content
ToolsForensic Analysisranbaxy pharmaceuticals

ranbaxy pharmaceuticals

Supplier Forensic Analysis · Scanned: 2026/05/24

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
3
Total Value
R 773M

Recent Awards

3 awards · Total: R 772 937 082

Showing 5 of 3
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AI
R 533 218 677
21 Aug 2025
SUPPLY AND DELIVERY OF CONTRACEPTIVES AND HORMONE MODULATING AGENTS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 1 OCTOBER 2023 TO 30 SEPTEMBER 2026
Health
Ref: HP03-2023CHM
R 58 491 576
15 Jun 2023
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AI
R 181 226 830
15 Jun 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Risk Assessment

Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →